Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.Financial_Report.xls
10-K - FORM 10-K - Oncologix Tech Inc.oncologix8312012.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Oncologix Tech Inc.R12.htm
EX-21 - SUBSIDIARIES OF ONCOLOGIX TECH, INC. - Oncologix Tech Inc.oncologix8312012exh21.htm
EX-99 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Oncologix Tech Inc.oncologix8312012exh99.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Oncologix Tech Inc.oncologix8312012exh312.htm
EX-32.1 - CERTIFICATION - Oncologix Tech Inc.oncologix8312012exh321.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Oncologix Tech Inc.oncologix8312012exh311.htm
EX-32.2 - CERTIFICATION - Oncologix Tech Inc.oncologix8312012exh322.htm
v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
12 Months Ended 15 Months Ended
Aug. 31, 2012
Aug. 31, 2011
Aug. 31, 2012
Operating activities:      
Net loss $ (285,569) $ (235,609) $ (333,999)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 450 1,471 966
Loss on disposal of property and equipment 110    110
Stock based compensation    464   
Amortization of discount on notes payable and warrants 10,000    10,000
Loss on conversion of notes payable - related parties 92,758    92,758
Induced conversion expense notes payable 25,402 6,076 31,478
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets 9,025 10,301 10,466
Accounts payable and other accrued expenses 3,189 8,732 (31,197)
Accrued interest payable - related parties 15,079 18,240 19,891
Accrued interest payable 10,175 11,787 13,117
Net cash used in operating activities (119,381) (178,538) (186,410)
Investing activities:      
Purchase of property and equipment (1,677)    (1,289)
Net cash used in investing activities (1,677)    (1,289)
Financing activities:      
Proceeds from issuance of convertible notes payable - related parties 20,000    20,000
Proceeds from issuance of notes payable - related parties 45,000 75,000 60,000
Proceeds from the issuance of common stock 75,000 175,000 175,000
Repayment of notes payable (8,078) (8,078) (9,926)
Repayment of notes payable - related parties    (60,661) (36,991)
Repayment of convertible notes payable    (2,252) (2,252)
Repayment of convertible notes payable - related parties (20,000)    (20,000)
Net cash provided by financing activities 111,922 179,009 185,831
Net increase (decrease) in cash and cash equivalents (9,136) 471 (1,868)
Cash and cash equivalents, beginning of period 11,067 10,596 3,799
Cash and cash equivalents, end of period $ 1,931 $ 11,067 $ 1,931